MECHANISMS OF ULTRAVIOLET LIGHT INDUCED P53 MUTATIONS

紫外线诱导 P53 突变的机制

基本信息

项目摘要

We developed ligation-mediated PCR (LMPCR) to map the frequency of mutagen-induced damage at nucleotide resolution and showed that the repair rate of UV-induced cyclopyrimidine dimers varies over fifteen fold from nucleotide position to nucleotide position. UV-induced cyclobutane dimers, if not repaired and subsequently misread by DNA polymerase result in mutations which, if they confer a tumorigenic growth advantage, appear in non-melanoma skin tumors. The major component of the UV-induced mutational signature is C->T transitions at dipyrimidine sites. We show that cyclobutane dimer repair rates along the p53 gene are highly correlated with the frequency each position appears as a C->T transition in the p53 mutation data base for non-melanoma skin tumors, but not for internal tumors. Thus, variation in cyclobutane dimer repair rate along the p53 gene drives a very significant fraction of the variation of the nucleotide position to nucleotide position mutation rate, mutational spectrum, of p53 mutations in skin tumors. With chronic UV doses, each nucleotide position reaches a steady state lesion equilibrium frequency, Leq. On finding that the kinetics of repair at any one nucleotide position are first order kinetics, we were able to show mathematically that Leq is the product of ease of damage after an acute UV dose times the half life for repair. As such, L incorporates two of the four sequential steps of mutagenesis and should be more highly correlated with C->T transition frequency than is repair rate alone. We will use ligation-mediated PCR to map Leq, Lacute, and repair rate in UV-B irradiated fibroblasts and keratinocytes using ligation-mediated PCR and determine which of these mutagenesis metrics best predicts the C->T transition frequency in the p53 mutation data base for non-melanoma skin tumors. Since cyclopyrimidine dimer repair rates vary with chronic dose strength (the adaptive response) and the environmentally relevant dose is a low one, we will map Leq at low UV doses to determine the correlation coefficient of the low dose Leq. To measure this, we will increase the sensitivity of LMPCR by size purification of p53 containing restriction fragments.
我们开发了连接介导的PCR (LMPCR)来绘制

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

GERALD P HOLMQUIST其他文献

GERALD P HOLMQUIST的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('GERALD P HOLMQUIST', 18)}}的其他基金

TUMORIGENICITY OF DIFFERENT P53 MISSENSE MUTATIONS
不同 P53 错义突变的致瘤性
  • 批准号:
    2465352
  • 财政年份:
    1998
  • 资助金额:
    $ 24.85万
  • 项目类别:
BASE EXCISION REPAIR AND MECHANISMS OF ALKYLATING AGENT INDUCED P53 DAMAGE
碱基切除修复和烷基化剂诱导 P53 损伤的机制
  • 批准号:
    6103191
  • 财政年份:
    1998
  • 资助金额:
    $ 24.85万
  • 项目类别:
TUMORIGENICITY OF DIFFERENT P53 MISSENSE MUTATIONS
不同 P53 错义突变的致瘤性
  • 批准号:
    2871994
  • 财政年份:
    1998
  • 资助金额:
    $ 24.85万
  • 项目类别:
MECHANISMS OF ULTRAVIOLET LIGHT INDUCED P53 MUTATIONS
紫外线诱导 P53 突变的机制
  • 批准号:
    6103189
  • 财政年份:
    1998
  • 资助金额:
    $ 24.85万
  • 项目类别:
TUMORIGENICITY OF DIFFERENT P53 MISSENSE MUTATIONS
不同 P53 错义突变的致瘤性
  • 批准号:
    6150297
  • 财政年份:
    1998
  • 资助金额:
    $ 24.85万
  • 项目类别:
BASE EXCISION REPAIR AND MECHANISMS OF ALKYLATING AGENT INDUCED P53 DAMAGE
碱基切除修复和烷基化剂诱导 P53 损伤的机制
  • 批准号:
    6237669
  • 财政年份:
    1997
  • 资助金额:
    $ 24.85万
  • 项目类别:
MECHANISMS OF P53 MUTAGENESIS
P53 诱变机制
  • 批准号:
    2769833
  • 财政年份:
    1996
  • 资助金额:
    $ 24.85万
  • 项目类别:
MECHANISMS OF P53 MUTAGENESIS
P53 诱变机制
  • 批准号:
    2113515
  • 财政年份:
    1996
  • 资助金额:
    $ 24.85万
  • 项目类别:
MECHANISMS OF P53 MUTAGENESIS
P53 诱变机制
  • 批准号:
    2517693
  • 财政年份:
    1996
  • 资助金额:
    $ 24.85万
  • 项目类别:
ADDUCT AND REPAIR MAPPING IN ONCOGENES
癌基因中的加合物和修复图谱
  • 批准号:
    3199311
  • 财政年份:
    1991
  • 资助金额:
    $ 24.85万
  • 项目类别:

相似海外基金

Glut1+ cancer associated fibroblasts enforce a metabolic barrier to tumor T cell infiltration
Glut1癌症相关成纤维细胞增强了肿瘤T细胞浸润的代谢屏障
  • 批准号:
    10752508
  • 财政年份:
    2024
  • 资助金额:
    $ 24.85万
  • 项目类别:
Depicting disease heterogeneity in neurofibromatosis type 1 and the role of dermal fibroblasts in the establishment of microenvironment favouring NF1-associated skin tumor formation using personalized tissue-engineered 3D models
使用个性化组织工程 3D 模型描述 1 型神经纤维瘤病的疾病异质性以及真皮成纤维细胞在建立有利于 NF1 相关皮肤肿瘤形成的微环境中的作用
  • 批准号:
    478062
  • 财政年份:
    2023
  • 资助金额:
    $ 24.85万
  • 项目类别:
    Operating Grants
Aging of cardiac fibroblasts and heart failure: novel heart failure treatment through regeneration and transplantation of cardiac fibroblasts
心脏成纤维细胞的衰老和心力衰竭:通过心脏成纤维细胞的再生和移植治疗心力衰竭
  • 批准号:
    23K07526
  • 财政年份:
    2023
  • 资助金额:
    $ 24.85万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analyzing the mechanism of the effects of Fusobacterium cooperated with cancer-associated fibroblasts on gastrointestinal cancers
梭杆菌协同癌相关成纤维细胞对胃肠道肿瘤的作用机制分析
  • 批准号:
    23K15435
  • 财政年份:
    2023
  • 资助金额:
    $ 24.85万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Unraveling the Heterogeneity of Cancer-Associated Fibroblasts through Intercellular Signaling
通过细胞间信号传导揭示癌症相关成纤维细胞的异质性
  • 批准号:
    23K18241
  • 财政年份:
    2023
  • 资助金额:
    $ 24.85万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
p16INK4a+ fibroblasts regulate epithelial regeneration after injury in lung alveoli through the SASP
p16INK4a成纤维细胞通过SASP调节肺泡损伤后的上皮再生
  • 批准号:
    10643269
  • 财政年份:
    2023
  • 资助金额:
    $ 24.85万
  • 项目类别:
CAR T cells targeting mesothelin and secreting bispecific antibodies targeting fibroblasts in pancreatic cancer
CAR T 细胞靶向间皮素并分泌靶向胰腺癌成纤维细胞的双特异性抗体
  • 批准号:
    10731635
  • 财政年份:
    2023
  • 资助金额:
    $ 24.85万
  • 项目类别:
HuR-Wisp1 signaling in cardiac fibroblasts
心脏成纤维细胞中的 HuR-Wisp1 信号传导
  • 批准号:
    10751223
  • 财政年份:
    2023
  • 资助金额:
    $ 24.85万
  • 项目类别:
Functional heterogeneity of cancer-associated fibroblasts in head and neck squamous cell carcinoma and development of therapeutic strategies
头颈鳞状细胞癌中癌症相关成纤维细胞的功能异质性及治疗策略的开发
  • 批准号:
    23K08956
  • 财政年份:
    2023
  • 资助金额:
    $ 24.85万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Elucidation of the mechanisms of tumor progression controlled by tumor-initiating cells and cancer-associated fibroblasts in pancreatic adenocarcinoma.
阐明胰腺腺癌中肿瘤起始细胞和癌症相关成纤维细胞控制的肿瘤进展机制。
  • 批准号:
    23K15075
  • 财政年份:
    2023
  • 资助金额:
    $ 24.85万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了